TriSalus Life Sciences (TLSI) Misses Q3 EPS by 96c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Wall St set for higher open as SpaceX, Super Micro results rekindle AI trade
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- AI bubble about to burst? Not yet, Yardeni says
- SpaceX tops Q3 estimates as revenue surges 161% on Starlink, AI compute expansion
Tweet
Share
E-mailGet Alerts TLSI Hot Sheet
Join SI Premium – FREE
TriSalus Life Sciences (NASDAQ: TLSI) reported Q3 EPS of ($0.96). Revenue for the quarter came in at $11.6 million.
For earnings history and earnings-related data on TriSalus Life Sciences (TLSI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays cuts Cirrus Logic price target to $95 from $130, cuts to Underweight
- Solaris Oilfield Infrastructure shares jump on Morgan Stanley upgrade
- StoneX Reiterates Buy Rating on The Chefs' Warehouse, Inc (CHEF) Ahead of Q3 Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
